Restoration of Sensorimotor Function in Middle-Aged Women With Chronic Lumbar Disc Herniation: The Effect of Pilates on Proprioception, Tibialis Anterior Strength, and Dynamic Balance (Chronic LDH)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lumbar disc herniation (LDH) is a common musculoskeletal disorder resulting from the degeneration of intervertebral discs in the lumbar spine and the compression of nerve roots. This condition leads to symptoms such as low back pain, numbness in the lower extremities, muscle weakness, and balance impairments, significantly limiting individuals' daily activities and quality of life.
Pilates is a mind-body exercise approach that focuses on the activation of deep core muscles (such as the transversus abdominis and multifidus), breathing control, and body awareness. This exercise model is thought to potentially reverse pain-induced cortical reorganization in the motor cortex and improve sensorimotor integration by promoting neuromuscular re-education.
Although the effects of Pilates on trunk proprioception have been investigated in the literature, studies specifically examining its impact on ankle proprioception and distal muscle strength in patients with LDH are limited. Therefore, the aim of this study is to investigate the effects of Pilates on the sensorimotor system in middle-aged women with chronic lumbar disc herniation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
onikişubat
-
Kahramanmaraş, onikişubat, Turkey (Türkiye), 46100
- Kahramanmaraş Sütçü İmam Üniversitesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
* Female individuals aged 45-60 years diagnosed with lumbar disc herniation (LDH),
- Individuals who were diagnosed with LDH at least one year prior,
- Individuals who have not received any therapeutic exercise treatment in the past year,
- Individuals without any communication impairments (visual or hearing),
- Individuals who have not undergone any surgical procedure within the last 6 months,
- Individuals who voluntarily agree to participate in the study.
Exclusion Criteria:
* Individuals who do not wish to participate in the study,
- Individuals who do not meet the age criteria,
- Individuals currently receiving therapeutic exercise treatment,
- Individuals with conditions that may affect ankle muscle strength and sensation (e.g., diabetes, rheumatologic diseases, neuromuscular disorders).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pİlates
İntervention : 8-week Pilates exercise program.
Individuals with chronic unilateral lumbar disc herniation (LDH) who continue their normal daily activities and meet the inclusion criteria will be enrolled in an 8-week Pilates exercise program, conducted twice a week for 50 minutes per session.
Assessments will be performed before and after the exercise program.
|
Pİlates Group: 8-week Pilates exercise program
Other Names:
|
|
No Intervention: Control
Individuals with chronic unilateral lumbar disc herniation (LDH) who continue their normal daily activities and meet the inclusion criteria will be evaluated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proprioceptive Sense/Joint Position Sense
Time Frame: From enrollment to the end of treatment at 8 weeks
|
Ankle joint position sense will be assessed to evaluate proprioceptive function. The assessment will be performed in a standing position. Reflective markers will be placed on anatomical landmarks used as pivot points for goniometric measurement of the ankle, and participants' feet will be labeled with their names to prevent any confusion. Participants will be asked to transfer their body weight onto one leg. During this, on the side to be measured, they will be instructed to maintain a position with the hip at 30° flexion and the knee at 60° flexion, lightly touching the ground with the toes. Two rigid devices providing 0° and 10° angles at the ankle joint will be used. The ankle will be positioned at the target angle using these devices, and the participant will be asked to hold this position for 5 seconds. Afterward, the foot will be returned to the initial position. Participants will then be asked to look straight ahead and actively reproduce the same ankle position, at which poi |
From enrollment to the end of treatment at 8 weeks
|
|
Tibialis Anterior Muscle Test
Time Frame: "From enrollment to the end of treatment at 8 weeks"
|
The strength of the tibialis anterior muscle will be measured using the Lafayette Muscle Testing device (Model 01165, FDA Medical, Canada).
The test will be conducted in a seated position.
Prior to the assessment, participants will be informed about the procedure, and similar to manual muscle testing, they will be asked to pull their ankle toward themselves with maximum effort.
|
"From enrollment to the end of treatment at 8 weeks"
|
|
Functional Reach Test
Time Frame: From enrollment to the end of treatment at 8 weeks
|
This test is a practically applicable assessment and is preferred in many studies for evaluating dynamic balance.
The only requirements for its administration are a measuring tape and sufficient space.
|
From enrollment to the end of treatment at 8 weeks
|
|
Time Up Go Test
Time Frame: From enrollment to the end of treatment at 8 weeks
|
Before the test, participants will be informed about the procedure and the test will be demonstrated.
Upon the "start" command, the participant will be asked to rise from a chair, walk around a target placed 3 meters away, and return to sit on the chair.
Timing will be measured using a stopwatch.
The test will be repeated three times, and the best time, in seconds, will be recorded.
|
From enrollment to the end of treatment at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Assesment
Time Frame: From enrollment to the end of treatment at 8 weeks
|
The Visual Analog Scale (VAS), which is widely used in studies for pain assessment due to its ease of use and practicality, will be employed to evaluate pain.
|
From enrollment to the end of treatment at 8 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026/046
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.